NCT07500298 2026-03-30Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal CancerM.D. Anderson Cancer CenterPhase 1 Not yet recruiting41 enrolled